Schedule 13D ownership disclosure

CYCLACEL PHARMACEUTICALS INC

Common Stock, par value $0.0001 per share · CUSIP: 23254L801

Event date: 2025-02-26

Filing-level shares
194,628,820.00
Percent of class
70.0%
  • Doris Wong Sing EeReported CIK 0001892421

    Shares: 194,628,820.00 · Class: 70.0%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001829126-25-001429
Form type
SCHEDULE 13D
Filer
Bio Green Med Solution, Inc.
CIK
CIK 1130166
Filed
Mar 04, 2025
Reporting period
Feb 26, 2025
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub